About REXOBOL-50 ALPHA PHARMA
REXOBOL-50 Alpha Pharma is a stanozolol-based oral steroid preparation formulated for laboratory research into androgenic receptor mechanisms and anabolic pathway modulation. This synthetic derivative of dihydrotestosterone presents unique structural modifications that make it valuable for investigating steroid receptor binding profiles and tissue-selective activity patterns. Manufactured by Alpha Pharma, each tablet contains 50mg of active compound, providing researchers with standardised dosing for controlled experimental protocols. The formulation enables detailed analysis of androgenic signalling cascades and protein synthesis regulation in cellular models. Research teams at Stroid UK Shop utilise this compound to examine steroid hormone receptor dynamics and downstream molecular effects in various tissue types.
Laboratory Applications
In experimental settings, researchers investigate stanozolol’s distinct pharmacological profile, including its reduced 5α-reductase activity and altered androgenic-to-anabolic ratios compared to parent compounds. Studies examine its interactions with sex hormone-binding globulin and hepatic metabolism pathways. The oral bioavailability characteristics make it particularly suitable for absorption and distribution studies in research models. Scientists analyse its effects on nitrogen retention mechanisms and collagen synthesis regulation in controlled laboratory environments. Comparative studies with other compounds available through our oral steroids category provide insights into structure-activity relationships and receptor selectivity patterns. Research applications extend to investigating metabolic effects on lipid profiles and examining potential hepatotoxicity mechanisms through biochemical marker analysis.
Technical Specifications
| Parameter | Value |
|---|---|
| Active Ingredient | Stanozolol |
| Concentration | 50mg per tablet |
| Manufacturer | Alpha Pharma |
| CAS Number | 10418-03-8 |
| Molecular Formula | C₂₁H₃₂N₂O |
| Molecular Weight | 328.49 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Research Grade | Laboratory standard |
Researchers studying peptide interactions may also examine compounds from our peptides collection for comparative molecular analysis. Cross-referencing with selective androgen receptor modulators provides comprehensive data on receptor binding specificity across different structural classes.
Research Compliance
REXOBOL-50 Alpha Pharma is supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or diagnostic applications. All research must comply with institutional guidelines and appropriate safety protocols. Researchers must possess relevant qualifications and conduct studies within licensed laboratory facilities with proper ventilation and safety equipment.
